Results 11 to 20 of about 18,145 (196)
Treatment of age-related macular degeneration: focus on ranibizumab
Clinical Ophthalmology, 2008 Martin S Spitzer, Focke Ziemssen, Karl U Bartz-Schmidt, Faik Gelisken, Peter SzurmanTuebingen University Eye Center, University of Tuebingen, GermanyAbstract: Ranibizumab, a humanized antigen-binding fragment (Fab) that binds all isoforms of VEGF-A ...
Martin S Spitzer +4 more
doaj +1 more source
Journal of International Medical Research, 2020 Objective To compare the efficacy of ranibizumab plus fufang xueshuantong capsule (cFXST) with the efficacy of ranibizumab alone in treatment of exudative age-related macular degeneration.
Haitao Pan, Qinghuai Liu
exaly +2 more sources
Clinical Ophthalmology, 2012 Patrick D Williams,1 David Callanan,1 Wayne Solley,1 Robert L Avery,2 Dante J Pieramici,2 Tom Aaberg31Texas Retina Associates, Dallas, TX, 2California Retina Consultants and Research Foundation, Santa Barbara, CA, 3Retinal Associates, Grand Rapids, MI ...
Williams PD +5 more
doaj +1 more source
Clinical Interventions in Aging, 2013 Angie HC Fong,1 Timothy YY Lai1,2 1Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong; 22010 Retina and Macula Centre, Tsimshatsui, Kowloon, Hong Kong Abstract: Neovascular ...
Fong AH, Lai TY
doaj +1 more source
ClinicoEconomics and Outcomes Research, 2015 Stephane A Régnier,1 William Malcolm,2 Jennifer Haig,3 Weiguang Xue41Novartis Pharma AG, Basel, Switzerland; 2Novartis Pharmaceuticals UK Ltd, Frimley Business Park, UK; 3Optum, Burlington, ON, Canada; 4Optum, Uxbridge, UKBackground: Ranibizumab ...
Régnier SA +3 more
doaj +1 more source
Therapeutics and Clinical Risk Management, 2012 Youxin Chen, Fei HanDepartment of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaAbstract: Wet age-related macular degeneration (AMD) causes severe vision loss due
Chen Y, Han F
doaj +1 more source
Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance [PDF]
Clinical Ophthalmology, 2018 Ali Dirani, Irmela Mantel Department of Ophthalmology, University of Lausanne, Jules Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland Purpose: To investigate whether tolerance to the anti-VEGF drug, ranibizumab, develops after ...
Dirani A, Mantel I
doaj +2 more sources
Efficacy of Combining Intravitreal Injections of Ranibizumab with Micropulse Diode Laser versus Intravitreal Injections of Ranibizumab Alone in Diabetic Macular Edema [PDF]
Al-Azhar International Medical Journal, 2023 Background: Diabetes mellitus problems lead to diabetes retinopathy (DRP) and diabetic macular edoema (DME), two retinal disorders.Aim of the study: the study designed to assess effectiveness of intravitreal ranibizumab injections versus intravitreal ...
ahmed omran +2 more
doaj +1 more source
Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting
Clinical Ophthalmology, 2012 Angela M Carneiro,1,2 Luis S Mendonça,1 Manuel S Falcão,1,2 Sofia L Fonseca,1 Elisete M Brandão,1 Fernando M Falcão-Reis1,21Department of Ophthalmology of Hospital de São João, Porto ...
Carneiro AM +5 more
doaj +1 more source
Biosimilar Versus Innovator Ranibizumab in Myopic CNVM: Comparative Real-World Outcomes- The BRIM Study [PDF]
Clinical OphthalmologyDebdulal Chakraborty,1 Tushar Kanti Sinha,1 Sourav Sinha,2 Rupak Kanti Biswas,2 Aniruddha Maiti,3 Krishnendu Nandi,2 Dinesh Rungta,1 Ranabir Bhattacharya1 1Vitreo-Retina Services, Disha Eye Hospitals, Kolkata, WB, India; 2Vitreo-retina Services ...
Chakraborty D +7 more
doaj +1 more source